Published in Urologe A on January 01, 1988
Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol (1996) 1.95
Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol (1995) 1.58
Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun (2000) 1.48
Malignant germ cell tumor of the contralateral testis after radiotherapy for testicular intraepithelial neoplasia. J Urol (2000) 1.45
FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med (1998) 1.43
Some anthropological aspects of the prehistoric Tyrolean ice man. Science (1992) 1.41
Involvement of the urogenital tract in patients with five or more separate malignant neoplasms. Case and review. Eur Urol (1998) 1.40
Detection of somatic changes in human renal cell carcinomas with oligonucleotide probes specific for simple repeat motifs. Genes Chromosomes Cancer (1993) 1.40
Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (1983) 1.33
The contribution of magnetic resonance imaging of the pelvic floor to the understanding of urinary incontinence. Br J Urol (1993) 1.25
The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol (2005) 1.18
Spontaneous retroperitoneal haemorrhage associated with renal disease. J R Coll Surg Edinb (1998) 1.17
Purification and partial characterization of human lymphoblast interferon. Proc Natl Acad Sci U S A (1979) 1.17
Crossing vessels at the ureteropelvic junction: detection with contrast-enhanced color Doppler imaging. Radiology (1999) 1.16
The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J Physiol (1987) 1.14
Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology (1994) 1.13
Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol (2001) 1.10
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue. Prostate Cancer Prostatic Dis (2003) 1.09
Non-traumatic rupture of the urinary tract during pregnancy. Br J Urol (1995) 1.09
Radical prostatectomy in patients with previous groin hernia repair using synthetic nonabsorbable mesh. Urol Int (2001) 1.06
Acetylcholine transport, storage, and release. Int Rev Neurobiol (1993) 1.06
Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals. J Neurophysiol (1999) 1.06
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Cancer Res (2001) 1.04
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer (2009) 1.04
Gemcitabine: a phase II study in patients with advanced renal cancer. Cancer Chemother Pharmacol (1996) 1.03
Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res (2004) 1.03
Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol (1987) 1.02
Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res (1989) 0.99
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. Muscle Nerve (1982) 0.98
Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci (1990) 0.98
MRI findings in cerebral fat embolism. Eur Radiol (1998) 0.97
Updated concepts and treatment of carcinoma in situ. Urol Oncol (2011) 0.96
Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann Neurol (1985) 0.96
Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res (1990) 0.95
[Solitary peritoneal carcinomatosis in prostate cancer]. Aktuelle Urol (2007) 0.95
Collaborative study for establishment of the European Pharmacopoeia BRP batch 1 for diphtheria toxin. Pharmeuropa Bio (2003) 0.94
Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients. Urology (1999) 0.93
Urachal signet-ring cell carcinoma, a rare variant of vesical adenocarcinoma: incidence and pathological criteria. J Urol (1978) 0.93
Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Urol Int (1996) 0.92
Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J Physiol (1994) 0.92
Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor? J Urol (1987) 0.92
Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous? Br J Dermatol (1999) 0.92
Synthesis and neuromuscular blocking activity of 16beta-piperidinosteroidal derivatives. Eur J Med Chem (2001) 0.91
Benefit for the patient of a teleradiology process certified to meet an international standard. J Telemed Telecare (2003) 0.90
PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. Cancer Lett (2001) 0.90
Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol (1995) 0.90
The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction. Neuroscience (1990) 0.90
[Prevention of catheter dislodgment: modified nephrostomy with pigtail and balloon]. Urologe A (2004) 0.90
[Clarification of vertebrogenic backache. X-ray, myelography, cerebrospinal fluid examination, computer tomography]. ZFA (Stuttgart) (1983) 0.90
Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium. J Physiol (1991) 0.89
p53 expression in Wilms' tumor: a possible role as prognostic factor. Int J Oncol (2001) 0.89
Virtual computed tomography colonoscopy: artifacts, image quality and radiation dose load in a cadaver study. Eur Radiol (2000) 0.89
Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. Br J Pharmacol (1997) 0.89
Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography. Radiology (1998) 0.88
Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas. J Urol (1991) 0.88
Determination of prostate gland volume by transrectal ultrasound: correlation with radical prostatectomy specimens. Eur Urol (1995) 0.88
Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract. Eur Urol (1995) 0.88
Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder. J Urol (1981) 0.88
Management of rectal injury during perineal prostatectomy. Urol Int (1995) 0.87
Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain Dev (2008) 0.86
Biological behaviour and DNA cytophotometry of urothelial bladder carcinoma. Br J Urol (1984) 0.86
Intra-urethral ultrasound in women with stress incontinence. Br J Urol (1994) 0.86
Urinary neopterin levels in acute viral hepatitis. Hepatology (1988) 0.86
Presynaptic function is altered in snake K+-depolarized motor nerve terminals containing compromised mitochondria. J Physiol (2001) 0.85
Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus (2005) 0.85
Purification and characterization of multiple components of human lymphoblastoid interferon-alpha. J Biol Chem (1992) 0.85
[Calcofluor-white staining in the identification of Pneumocystis carinii]. Pneumologie (1992) 0.85
Urothelial dysplasia and carcinoma in situ of the bladder. Cancer (1986) 0.84
Blood pressure changes after extracorporeal shock wave nephrolithotripsy: prediction by intrarenal resistive index. Eur Radiol (1996) 0.84
The long-term results of surgical correction of childhood esotropia. Aust N Z J Ophthalmol (1993) 0.84
Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction. Br J Anaesth (1992) 0.83
A comparative study of stereolithographically modelled skulls of Petralona and Broken Hill: implications for future studies of middle Pleistocene hominid evolution. J Hum Evol (1997) 0.83
The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. Curr Med Chem (2012) 0.83
[Ultrasound contrast agents and prostate cancer]. Radiologe (2005) 0.83
Interferon in lungs. Lancet (1989) 0.83
Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction. BJU Int (2000) 0.83
Carcinoma in situ of the bladder extending into the seminal vesicles. J Urol (1987) 0.82
Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra. Int J Urol (1995) 0.82
Spontaneous kidney rupture due to a metastatic renal tumour. Case report. Scand J Urol Nephrol (1994) 0.82
A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity. Br J Pharmacol (1988) 0.82
alpha-Conotoxin GI produces tetanic fade at the rat neuromuscular junction. Toxicon (1992) 0.82
Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate? Eur Urol (1998) 0.82
3-Dimensional computerized tomography and virtual reality endoscopy of the reconstructed lower urinary tract. J Urol (1998) 0.82
Adenocarcinoma of the urachus: 3 case reports and a review of the literature. Acta Urol Belg (1997) 0.82
Evaluation of possible tissue damage in patients undergoing extracorporeal shock wave lithotripsy employing C-reactive protein. Scand J Urol Nephrol (1997) 0.81
Polyploidization and losses of chromosomes 1, 2, 6, 10, 13, and 17 in three cases of chromophobe renal cell carcinomas. Cancer Genet Cytogenet (1999) 0.81
Reconstruction of abdominal wall and mons pubis in females with bladder exstrophy. Urology (1983) 0.81
The effects of chloramphenicol isomers on the motor end-plate nicotinic receptor-ion channel complex. Mol Pharmacol (1986) 0.81
Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. Nucleosides Nucleotides Nucleic Acids (2006) 0.81
Combined cis-platinum and radiation therapy in patients with stages pT3 and pT4 bladder cancer: a pilot study. J Urol (1983) 0.80
Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasia. Br J Urol (1996) 0.80
[Assessment of renal resistance index in children with vesico-ureteral reflux]. Ultraschall Med (1999) 0.80
Prejunctional effects of the nicotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction. J Physiol (1998) 0.80
Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasia. Br J Urol (1998) 0.80
Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer. Anticancer Res (1999) 0.80
Epidemiology and biology of human urinary bladder cancer. J Cancer Res Clin Oncol (2000) 0.80
Interactions between bladder tumor cells as tumor spheroids from the cell line J82 and human endothelial cells in vitro. J Urol (1988) 0.80
Urinary neopterin, a marker of clinical activity in patients with Crohn's disease. Clin Chim Acta (1986) 0.80
Cloning and sequence of the LYS2 homologue gene from the osmotolerant yeast Pichia sorbitophila. Yeast (2001) 0.80